Chinese General Practice ›› 2022, Vol. 25 ›› Issue (27): 3395-3403.DOI: 10.12114/j.issn.1007-9572.2022.0201
Special Issue: 中医最新文章合集; 泌尿系统疾病最新文章合集; 高血压最新文章合集
• Article • Previous Articles Next Articles
Received:
2022-03-22
Revised:
2022-04-28
Published:
2022-09-20
Online:
2022-05-26
Contact:
Xiangmei CHEN
About author:
通讯作者:
陈香美
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0201
组别 | 例数 | 男性〔n(%)〕 | 年龄( | BMI( | 吸烟史〔n(%)〕 | 饮酒史〔n(%)〕 | 首发临床症状〔n(%)〕 | 高血压史〔n(%)〕 | |||
---|---|---|---|---|---|---|---|---|---|---|---|
尿检异常 | 肉眼血尿 | 水肿 | 头痛头晕或恶心呕吐 | ||||||||
IgAN组 | 85 | 47(55.3) | 38.0±10.9 | 24.7±3.8 | 27(31.8) | 32(37.6) | 63(74.1) | 12(14.1) | 9(10.6) | 5(5.9) | 35(41.2) |
IgAN-MHT组 | 17 | 11(64.7) | 33.4±11.0 | 24.2±4.0 | 3(17.6) | 5(29.4) | 7(41.2) | 0 | 4(23.5) | 7(41.2) | 2(11.8) |
检验统计量值 | 0.512a | 1.560b | 0.553b | 1.360a | 0.416a | 7.140a | 1.530a | 1.128a | 13.770a | 5.301a | |
P值 | 0.474 | 0.122 | 0.581 | 0.244 | 0.519 | 0.008 | 0.216 | 0.288 | <0.001 | 0.021 | |
组别 | 临床诊断〔n(%)〕 | 入院时平均动脉压〔M(P25,P75),mm Hg〕 | 最高收缩压〔M(P25,P75),mm Hg〕d | 最高舒张压〔M(P25,P75),mm Hg〕d | 丙氨酸氨基转移酶〔M(P25,P75),U/L〕 | ||||||
慢性肾炎综合征 | 肾病综合征 | 急性肾损伤 | |||||||||
IgAN组 | 84(98.8) | 1(1.2) | 0 | 97(89,105) | 160(147,175) | 100(100,110) | 14.2(10.3,20.8) | ||||
IgAN-MHT组 | 10(58.8) | 4(23.5) | 1(5.9) | 101(93,113) | 200(185,215) | 140(130,145) | 11.5(9.9,19.5) | ||||
检验统计量值 | 26.070a | —c | —c | -2.017 | -5.041 | -5.599 | -0.799 | ||||
P值 | <0.001 | 0.003 | 0.167 | 0.044 | <0.001 | <0.001 | 0.424 | ||||
组别 | 天冬氨酸氨基转移酶〔M(P25,P75),U/L〕 | 血清总蛋白〔M(P25,P75),g/L〕 | 白蛋白〔M(P25,P75),g/L〕 | 血葡萄糖( | 血尿素氮〔M(P25,P75),mmol/L〕 | 血肌酐〔M(P25,P75),μmol/L〕 | 血尿酸〔M(P25,P75),μmol/L〕 | 总胆固醇〔M(P25,P75),mmol/L〕 | |||
IgAN组 | 15.0(12.4,18.8) | 65.1(62.1,71.0) | 39.3(36.0,42.3) | 5.1±1.0 | 5.6(4.4,6.8) | 98.2(74.3,123.3) | 374.5(295.7,447.0) | 4.4(3.6,5.0) | |||
IgAN-MHT组 | 12.3(11.5,16.6) | 60.3(56.7,69.9) | 38.0(34.3,41.2) | 4.6±0.7 | 8.0(6.4,15.6) | 171.4(105.7,391.2) | 428.4(357.7,451.2) | 4.2(3.6,4.7) | |||
检验统计量值 | -1.747 | -1.670 | -1.280 | 1.956b | -4.117 | -3.637 | -1.863 | -0.144 | |||
P值 | 0.081 | 0.095 | 0.201 | 0.053 | <0.001 | <0.001 | 0.062 | 0.886 | |||
组别 | 三酰甘油〔M(P25,P75),mmol/L〕 | 高密度脂蛋白〔M(P25,P75),mmol/L〕 | 低密度脂蛋白〔M(P25,P75),mmol/L〕 | 钙( | 无机磷〔M(P25,P75),mmol/L〕 | 镁〔M(P25,P75),mmol/L〕 | 钾( | 钠( | 补体C3〔M(P25,P75),mg/dl〕 | ||
IgAN组 | 1.7(1.3,2.5) | 1.0(0.8,1.3) | 2.8(2.3,3.2) | 2.2±0.1 | 1.2(1.0,1.3) | 0.8(0.8,0.9) | 4.0±0.3 | 141.1±2.1 | 106.0(94.6,120.0) | ||
IgAN-MHT组 | 1.6(1.2,2.0) | 0.8(0.7,1.2) | 2.7(2.2,3.3) | 2.2±0.1 | 1.3(1.1,1.7) | 0.9(0.9,0.9) | 4.2±0.6 | 140.7±2.7 | 109.0(82.9,122.0) | ||
检验统计量值 | -0.804 | -1.280 | -0.260 | 0.511b | -2.048 | -2.366 | -1.847b | 0.564b | -0.445 | ||
P值 | 0.422 | 0.201 | 0.795 | 0.610 | 0.041 | 0.018 | 0.068 | 0.574 | 0.657 | ||
组别 | 补体C4( | 血IgA〔M(P25,P75),mg/dl〕 | 血IgE〔M(P25,P75),IU/ml〕 | 血IgG〔M(P25,P75),mg/dl〕 | 血IgM〔M(P25,P75),mg/dl〕 | 24 h尿蛋白定量〔M(P25,P75),g/24 h〕 | 24 h尿蛋白定量分级〔n(%)〕 | ||||
<1 g/24 h | 1~3.5 g/24 h | ≥3.5 g/24 h | |||||||||
IgAN组 | 25.6±7.0 | 291.0(221.0,361.0) | 45.8(19.8,93.2) | 1 130.0(951.0,1 275.0) | 103.0(67.1,146.0) | 1.0(0.6,1.9) | 40(47.1) | 43(50.6) | 2(2.4) | ||
IgAN-MHT组 | 27.2±8.4 | 314.0(246.0,374.5) | 75.3(30.8,230.0) | 959.0(716.5,1 135.0) | 65.4(40.2,107.3) | 2.0(1.4,3.9) | 2(11.8) | 9(52.9) | 6(35.3) | ||
检验统计量值 | -0.808b | -0.673 | -1.598 | -2.155 | -2.492 | -3.444 | 18.920a | ||||
P值 | 0.421 | 0.501 | 0.110 | 0.031 | 0.013 | 0.001 | <0.001 | ||||
组别 | 血红蛋白( | 血小板计数( | 尿红细胞检查(镜检)〔M(P25,P75),/HPF〕 | eGFR〔M(P25,P75),ml·min-1·(1.73 m2)-1〕 | CKD分期〔n(%)〕 | ||||||
1 | 2 | 3a | 3b | 4 | 5 | ||||||
IgAN组 | 131.0±17.7 | 243.7±54.8 | 6.5(3.0,18.3) | 80.5(57.3,105.4) | 33(38.8) | 28(32.9) | 13(15.3) | 9(10.6) | 2(2.4) | 0 | |
IgAN-MHT组 | 129.4±23.3 | 225.1±55.6 | 4.0(0.5,11.8) | 46.7(19.1,76.9) | 1(5.9) | 5(29.4) | 3(17.6) | 3(17.6) | 2(11.8) | 3(17.6) | |
检验统计量值 | 0.310b | 1.277b | -1.130 | -3.722 | 19.122c | ||||||
P值 | 0.757 | 0.205 | 0.259 | <0.001 | 0.001 |
Table 1 Comparison of clinical data of IgA nephropathy patients with and without malignant hypertension
组别 | 例数 | 男性〔n(%)〕 | 年龄( | BMI( | 吸烟史〔n(%)〕 | 饮酒史〔n(%)〕 | 首发临床症状〔n(%)〕 | 高血压史〔n(%)〕 | |||
---|---|---|---|---|---|---|---|---|---|---|---|
尿检异常 | 肉眼血尿 | 水肿 | 头痛头晕或恶心呕吐 | ||||||||
IgAN组 | 85 | 47(55.3) | 38.0±10.9 | 24.7±3.8 | 27(31.8) | 32(37.6) | 63(74.1) | 12(14.1) | 9(10.6) | 5(5.9) | 35(41.2) |
IgAN-MHT组 | 17 | 11(64.7) | 33.4±11.0 | 24.2±4.0 | 3(17.6) | 5(29.4) | 7(41.2) | 0 | 4(23.5) | 7(41.2) | 2(11.8) |
检验统计量值 | 0.512a | 1.560b | 0.553b | 1.360a | 0.416a | 7.140a | 1.530a | 1.128a | 13.770a | 5.301a | |
P值 | 0.474 | 0.122 | 0.581 | 0.244 | 0.519 | 0.008 | 0.216 | 0.288 | <0.001 | 0.021 | |
组别 | 临床诊断〔n(%)〕 | 入院时平均动脉压〔M(P25,P75),mm Hg〕 | 最高收缩压〔M(P25,P75),mm Hg〕d | 最高舒张压〔M(P25,P75),mm Hg〕d | 丙氨酸氨基转移酶〔M(P25,P75),U/L〕 | ||||||
慢性肾炎综合征 | 肾病综合征 | 急性肾损伤 | |||||||||
IgAN组 | 84(98.8) | 1(1.2) | 0 | 97(89,105) | 160(147,175) | 100(100,110) | 14.2(10.3,20.8) | ||||
IgAN-MHT组 | 10(58.8) | 4(23.5) | 1(5.9) | 101(93,113) | 200(185,215) | 140(130,145) | 11.5(9.9,19.5) | ||||
检验统计量值 | 26.070a | —c | —c | -2.017 | -5.041 | -5.599 | -0.799 | ||||
P值 | <0.001 | 0.003 | 0.167 | 0.044 | <0.001 | <0.001 | 0.424 | ||||
组别 | 天冬氨酸氨基转移酶〔M(P25,P75),U/L〕 | 血清总蛋白〔M(P25,P75),g/L〕 | 白蛋白〔M(P25,P75),g/L〕 | 血葡萄糖( | 血尿素氮〔M(P25,P75),mmol/L〕 | 血肌酐〔M(P25,P75),μmol/L〕 | 血尿酸〔M(P25,P75),μmol/L〕 | 总胆固醇〔M(P25,P75),mmol/L〕 | |||
IgAN组 | 15.0(12.4,18.8) | 65.1(62.1,71.0) | 39.3(36.0,42.3) | 5.1±1.0 | 5.6(4.4,6.8) | 98.2(74.3,123.3) | 374.5(295.7,447.0) | 4.4(3.6,5.0) | |||
IgAN-MHT组 | 12.3(11.5,16.6) | 60.3(56.7,69.9) | 38.0(34.3,41.2) | 4.6±0.7 | 8.0(6.4,15.6) | 171.4(105.7,391.2) | 428.4(357.7,451.2) | 4.2(3.6,4.7) | |||
检验统计量值 | -1.747 | -1.670 | -1.280 | 1.956b | -4.117 | -3.637 | -1.863 | -0.144 | |||
P值 | 0.081 | 0.095 | 0.201 | 0.053 | <0.001 | <0.001 | 0.062 | 0.886 | |||
组别 | 三酰甘油〔M(P25,P75),mmol/L〕 | 高密度脂蛋白〔M(P25,P75),mmol/L〕 | 低密度脂蛋白〔M(P25,P75),mmol/L〕 | 钙( | 无机磷〔M(P25,P75),mmol/L〕 | 镁〔M(P25,P75),mmol/L〕 | 钾( | 钠( | 补体C3〔M(P25,P75),mg/dl〕 | ||
IgAN组 | 1.7(1.3,2.5) | 1.0(0.8,1.3) | 2.8(2.3,3.2) | 2.2±0.1 | 1.2(1.0,1.3) | 0.8(0.8,0.9) | 4.0±0.3 | 141.1±2.1 | 106.0(94.6,120.0) | ||
IgAN-MHT组 | 1.6(1.2,2.0) | 0.8(0.7,1.2) | 2.7(2.2,3.3) | 2.2±0.1 | 1.3(1.1,1.7) | 0.9(0.9,0.9) | 4.2±0.6 | 140.7±2.7 | 109.0(82.9,122.0) | ||
检验统计量值 | -0.804 | -1.280 | -0.260 | 0.511b | -2.048 | -2.366 | -1.847b | 0.564b | -0.445 | ||
P值 | 0.422 | 0.201 | 0.795 | 0.610 | 0.041 | 0.018 | 0.068 | 0.574 | 0.657 | ||
组别 | 补体C4( | 血IgA〔M(P25,P75),mg/dl〕 | 血IgE〔M(P25,P75),IU/ml〕 | 血IgG〔M(P25,P75),mg/dl〕 | 血IgM〔M(P25,P75),mg/dl〕 | 24 h尿蛋白定量〔M(P25,P75),g/24 h〕 | 24 h尿蛋白定量分级〔n(%)〕 | ||||
<1 g/24 h | 1~3.5 g/24 h | ≥3.5 g/24 h | |||||||||
IgAN组 | 25.6±7.0 | 291.0(221.0,361.0) | 45.8(19.8,93.2) | 1 130.0(951.0,1 275.0) | 103.0(67.1,146.0) | 1.0(0.6,1.9) | 40(47.1) | 43(50.6) | 2(2.4) | ||
IgAN-MHT组 | 27.2±8.4 | 314.0(246.0,374.5) | 75.3(30.8,230.0) | 959.0(716.5,1 135.0) | 65.4(40.2,107.3) | 2.0(1.4,3.9) | 2(11.8) | 9(52.9) | 6(35.3) | ||
检验统计量值 | -0.808b | -0.673 | -1.598 | -2.155 | -2.492 | -3.444 | 18.920a | ||||
P值 | 0.421 | 0.501 | 0.110 | 0.031 | 0.013 | 0.001 | <0.001 | ||||
组别 | 血红蛋白( | 血小板计数( | 尿红细胞检查(镜检)〔M(P25,P75),/HPF〕 | eGFR〔M(P25,P75),ml·min-1·(1.73 m2)-1〕 | CKD分期〔n(%)〕 | ||||||
1 | 2 | 3a | 3b | 4 | 5 | ||||||
IgAN组 | 131.0±17.7 | 243.7±54.8 | 6.5(3.0,18.3) | 80.5(57.3,105.4) | 33(38.8) | 28(32.9) | 13(15.3) | 9(10.6) | 2(2.4) | 0 | |
IgAN-MHT组 | 129.4±23.3 | 225.1±55.6 | 4.0(0.5,11.8) | 46.7(19.1,76.9) | 1(5.9) | 5(29.4) | 3(17.6) | 3(17.6) | 2(11.8) | 3(17.6) | |
检验统计量值 | 0.310b | 1.277b | -1.130 | -3.722 | 19.122c | ||||||
P值 | 0.757 | 0.205 | 0.259 | <0.001 | 0.001 |
组别 | 例数 | 主证 | 兼证 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
肺脾气虚证 | 气阴两虚证 | 肝肾阴虚证 | 脾肾阳虚证 | 水湿 | 痰湿 | 湿热 | 寒湿 | 血瘀 | 肝郁 | 浊毒 | ||
IgAN组 | 85 | 15(17.6) | 39(45.9) | 18(21.2) | 13(15.3) | 9(10.6) | 10(11.8) | 22(25.9) | 1(1.2) | 20(23.5) | 16(18.8) | 7(8.2) |
IgAN-MHT组 | 17 | 4(23.5) | 7(41.2) | 3(17.6) | 3(17.6) | 3(17.6) | 1(5.9) | 5(29.4) | 0 | 9(52.9) | 3(17.6) | 0 |
χ2值 | 0.052 | 0.127 | 0 | 0 | 0.170 | 0.082 | 0 | — | 4.664 | 0 | 0.491 | |
P值 | 0.820 | 0.722 | 1 | 1 | 0.680 | 0.775 | 1 | 1 | 0.031 | 1 | 0.484 |
Table 2 Comparison of main syndromes and concurrent syndromes of TCM in IgA nephropathy patients with and without malignant hypertension
组别 | 例数 | 主证 | 兼证 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
肺脾气虚证 | 气阴两虚证 | 肝肾阴虚证 | 脾肾阳虚证 | 水湿 | 痰湿 | 湿热 | 寒湿 | 血瘀 | 肝郁 | 浊毒 | ||
IgAN组 | 85 | 15(17.6) | 39(45.9) | 18(21.2) | 13(15.3) | 9(10.6) | 10(11.8) | 22(25.9) | 1(1.2) | 20(23.5) | 16(18.8) | 7(8.2) |
IgAN-MHT组 | 17 | 4(23.5) | 7(41.2) | 3(17.6) | 3(17.6) | 3(17.6) | 1(5.9) | 5(29.4) | 0 | 9(52.9) | 3(17.6) | 0 |
χ2值 | 0.052 | 0.127 | 0 | 0 | 0.170 | 0.082 | 0 | — | 4.664 | 0 | 0.491 | |
P值 | 0.820 | 0.722 | 1 | 1 | 0.680 | 0.775 | 1 | 1 | 0.031 | 1 | 0.484 |
组别 | 例数 | 气虚证 | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
易感冒 | 神疲乏力 | 少气懒言 | 自汗 | 四肢倦怠 | 胫酸腿软 | 头目眩晕 | 头痛 | 恶心 | 呕吐 | 便溏 | ||
IgAN组 | 85 | 30(35.3) | 40(47.1) | 17(20.0) | 33(38.8) | 14(16.5) | 4(4.7) | 22(25.9) | 18(21.2) | 7(8.2) | 3(3.5) | 10(11.8) |
IgAN-MHT组 | 17 | 4(23.5) | 13(76.5) | 7(41.2) | 5(29.4) | 7(41.2) | 5(29.4) | 10(58.8) | 12(70.6) | 5(29.4) | 4(23.5) | 4(23.5) |
χ2值 | 0.882 | 4.910 | 2.452 | 0.537 | 3.886 | 7.897 | 7.140 | 16.66 | 4.250 | 6.013 | 0.811 | |
P值 | 0.348 | 0.027 | 0.117 | 0.464 | 0.049 | 0.005 | 0.008 | <0.001 | 0.039 | 0.014 | 0.368 | |
组别 | 阴虚证 | 血瘀证 | ||||||||||
视物模糊 | 飞蚊症 | 耳聋 | 手足心热 | 盗汗 | 口干/咽燥 | 舌苔干燥 | 面色黧黑 | 爪甲青紫 | 定位刺痛、夜间加重 | 舌色紫暗 | ||
IgAN组 | 21(24.7) | 3(3.5) | 6(7.1) | 34(40.0) | 18(21.2) | 28(32.9) | 7(8.2) | 16(18.8) | 2(2.4) | 7(8.2) | 17(20.0) | |
IgAN-MHT组 | 12(70.6) | 6(35.3) | 5(29.4) | 7(41.2) | 4(23.5) | 7(41.2) | 5(29.4) | 5(29.4) | 4(23.5) | 2(11.8) | 8(47.1) | |
χ2值 | 13.627 | 14.039 | 5.217 | 0.008 | 0 | 0.426 | 4.25 | 0.432 | 7.969 | 0 | 4.239 | |
P值 | <0.001 | <0.001 | 0.022 | 0.928 | 1 | 0.514 | 0.039 | 0.511 | 0.005 | 1 | 0.040 |
Table 3 Comparison of TCM symptoms in IgA nephropathy patients with and without malignant hypertension
组别 | 例数 | 气虚证 | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
易感冒 | 神疲乏力 | 少气懒言 | 自汗 | 四肢倦怠 | 胫酸腿软 | 头目眩晕 | 头痛 | 恶心 | 呕吐 | 便溏 | ||
IgAN组 | 85 | 30(35.3) | 40(47.1) | 17(20.0) | 33(38.8) | 14(16.5) | 4(4.7) | 22(25.9) | 18(21.2) | 7(8.2) | 3(3.5) | 10(11.8) |
IgAN-MHT组 | 17 | 4(23.5) | 13(76.5) | 7(41.2) | 5(29.4) | 7(41.2) | 5(29.4) | 10(58.8) | 12(70.6) | 5(29.4) | 4(23.5) | 4(23.5) |
χ2值 | 0.882 | 4.910 | 2.452 | 0.537 | 3.886 | 7.897 | 7.140 | 16.66 | 4.250 | 6.013 | 0.811 | |
P值 | 0.348 | 0.027 | 0.117 | 0.464 | 0.049 | 0.005 | 0.008 | <0.001 | 0.039 | 0.014 | 0.368 | |
组别 | 阴虚证 | 血瘀证 | ||||||||||
视物模糊 | 飞蚊症 | 耳聋 | 手足心热 | 盗汗 | 口干/咽燥 | 舌苔干燥 | 面色黧黑 | 爪甲青紫 | 定位刺痛、夜间加重 | 舌色紫暗 | ||
IgAN组 | 21(24.7) | 3(3.5) | 6(7.1) | 34(40.0) | 18(21.2) | 28(32.9) | 7(8.2) | 16(18.8) | 2(2.4) | 7(8.2) | 17(20.0) | |
IgAN-MHT组 | 12(70.6) | 6(35.3) | 5(29.4) | 7(41.2) | 4(23.5) | 7(41.2) | 5(29.4) | 5(29.4) | 4(23.5) | 2(11.8) | 8(47.1) | |
χ2值 | 13.627 | 14.039 | 5.217 | 0.008 | 0 | 0.426 | 4.25 | 0.432 | 7.969 | 0 | 4.239 | |
P值 | <0.001 | <0.001 | 0.022 | 0.928 | 1 | 0.514 | 0.039 | 0.511 | 0.005 | 1 | 0.040 |
组别 | 例数 | M病变 | E病变 | S病变 | T病变 | C病变 | 肾内动脉硬化 | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
M0 | M1 | E0 | E1 | S0 | S1 | T0 | T1 | T2 | C0 | C1 | C2 | |||
IgAN组 | 85 | 48(56.5) | 37(43.5) | 66(77.6) | 19(22.4) | 27(31.8) | 58(68.2) | 40(47.1) | 34(40.0) | 11(12.9) | 60(70.6) | 24(28.2) | 1(1.2) | 55(64.7) |
IgAN-MHT组 | 17 | 11(64.7) | 6(35.3) | 16(94.1) | 1(5.9) | 1(5.9) | 16(94.1) | 3(17.6) | 4(23.5) | 10(58.8) | 11(64.7) | 6(35.3) | 0 | 16(94.1) |
χ2值 | 0.394 | 1.505 | 3.554 | 15.515 | — | 5.793 | ||||||||
P值 | 0.530 | 0.220 | 0.059 | <0.001 | 0.644 | 0.016 |
Table 4 Comparison of Oxford classification of IgA nephropathy in IgA nephropathy patients with and without malignant hypertension
组别 | 例数 | M病变 | E病变 | S病变 | T病变 | C病变 | 肾内动脉硬化 | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
M0 | M1 | E0 | E1 | S0 | S1 | T0 | T1 | T2 | C0 | C1 | C2 | |||
IgAN组 | 85 | 48(56.5) | 37(43.5) | 66(77.6) | 19(22.4) | 27(31.8) | 58(68.2) | 40(47.1) | 34(40.0) | 11(12.9) | 60(70.6) | 24(28.2) | 1(1.2) | 55(64.7) |
IgAN-MHT组 | 17 | 11(64.7) | 6(35.3) | 16(94.1) | 1(5.9) | 1(5.9) | 16(94.1) | 3(17.6) | 4(23.5) | 10(58.8) | 11(64.7) | 6(35.3) | 0 | 16(94.1) |
χ2值 | 0.394 | 1.505 | 3.554 | 15.515 | — | 5.793 | ||||||||
P值 | 0.530 | 0.220 | 0.059 | <0.001 | 0.644 | 0.016 |
指标 | IgAN-MHT | |
---|---|---|
rs值 | P值 | |
气虚证 | 0.009 | 0.928 |
阴虚证 | -0.065 | 0.519 |
水湿证 | 0.082 | 0.415 |
痰湿证 | -0.071 | 0.480 |
湿热证 | 0.030 | 0.766 |
寒湿证 | -0.044 | 0.657 |
血瘀证 | 0.664 | <0.001 |
肝郁证 | 0.044 | 0.659 |
浊毒证 | -0.121 | 0.224 |
Table 5 Correlation of malignant hypertension in IgA nephropathy with TCM syndromes
指标 | IgAN-MHT | |
---|---|---|
rs值 | P值 | |
气虚证 | 0.009 | 0.928 |
阴虚证 | -0.065 | 0.519 |
水湿证 | 0.082 | 0.415 |
痰湿证 | -0.071 | 0.480 |
湿热证 | 0.030 | 0.766 |
寒湿证 | -0.044 | 0.657 |
血瘀证 | 0.664 | <0.001 |
肝郁证 | 0.044 | 0.659 |
浊毒证 | -0.121 | 0.224 |
临床指标 | 气虚证 | 阴虚证 | 血瘀证 | |||
---|---|---|---|---|---|---|
rs值 | P值 | rs值 | P值 | rs值 | P值 | |
性别(以女性为参照) | 0.485 | 0.049 | 0.118 | 0.653 | -0.044 | 0.868 |
年龄 | -0.151 | 0.563 | 0.012 | 0.963 | -0.096 | 0.713 |
吸烟史 | 0.019 | 0.942 | -0.240 | 0.354 | -0.182 | 0.485 |
饮酒史 | 0.207 | 0.426 | -0.247 | 0.339 | -0.167 | 0.521 |
入院时收缩压 | -0.013 | 0.962 | 0.539 | 0.025 | 0.133 | 0.611 |
入院时舒张压 | 0.025 | 0.924 | 0.343 | 0.178 | 0.060 | 0.818 |
丙氨酸氨基转移酶 | 0.050 | 0.848 | 0.024 | 0.926 | 0.192 | 0.459 |
天冬氨酸氨基转移酶 | 0.138 | 0.597 | 0.232 | 0.370 | 0.132 | 0.612 |
血清总蛋白 | -0.176 | 0.499 | 0.293 | 0.254 | -0.072 | 0.783 |
白蛋白 | -0.151 | 0.564 | 0.293 | 0.254 | 0 | 1.000 |
血葡萄糖 | 0.025 | 0.924 | 0.110 | 0.675 | -0.193 | 0.459 |
血尿素氮 | 0.302 | 0.240 | -0.244 | 0.345 | -0.048 | 0.855 |
血肌酐 | 0.427 | 0.087 | -0.317 | 0.215 | -0.072 | 0.783 |
血尿酸 | 0.377 | 0.136 | -0.415 | 0.098 | -0.072 | 0.783 |
总胆固醇 | 0.151 | 0.564 | -0.244 | 0.345 | -0.313 | 0.222 |
三酰甘油 | 0.251 | 0.331 | -0.244 | 0.345 | -0.361 | 0.155 |
高密度脂蛋白 | 0.031 | 0.911 | 0.346 | 0.206 | 0.278 | 0.315 |
低密度脂蛋白 | 0.047 | 0.867 | -0.142 | 0.614 | -0.139 | 0.620 |
钙 | 0.038 | 0.886 | 0.244 | 0.345 | -0.096 | 0.713 |
无机磷 | 0.176 | 0.499 | -0.525 | 0.030 | 0.072 | 0.783 |
镁 | 0.417 | 0.096 | 0.012 | 0.963 | -0.012 | 0.963 |
钾 | 0.201 | 0.439 | -0.634 | 0.006 | -0.409 | 0.103 |
钠 | -0.226 | 0.383 | -0.305 | 0.234 | -0.144 | 0.580 |
24 h尿蛋白定量 | 0.503 | 0.040 | -0.366 | 0.149 | -0.361 | 0.155 |
血红蛋白 | 0.251 | 0.330 | -0.085 | 0.744 | -0.156 | 0.549 |
血小板计数 | -0.063 | 0.811 | -0.232 | 0.370 | -0.289 | 0.261 |
尿红细胞检查(镜检)/HPF | -0.202 | 0.436 | -0.147 | 0.572 | 0.085 | 0.746 |
eGFR | -0.352 | 0.166 | 0.268 | 0.298 | 0.072 | 0.783 |
Table 6 Correlation analysis of Western medicine clinical indicators and TCM syndromes in IgA nephropathy patients with malignant hypertension
临床指标 | 气虚证 | 阴虚证 | 血瘀证 | |||
---|---|---|---|---|---|---|
rs值 | P值 | rs值 | P值 | rs值 | P值 | |
性别(以女性为参照) | 0.485 | 0.049 | 0.118 | 0.653 | -0.044 | 0.868 |
年龄 | -0.151 | 0.563 | 0.012 | 0.963 | -0.096 | 0.713 |
吸烟史 | 0.019 | 0.942 | -0.240 | 0.354 | -0.182 | 0.485 |
饮酒史 | 0.207 | 0.426 | -0.247 | 0.339 | -0.167 | 0.521 |
入院时收缩压 | -0.013 | 0.962 | 0.539 | 0.025 | 0.133 | 0.611 |
入院时舒张压 | 0.025 | 0.924 | 0.343 | 0.178 | 0.060 | 0.818 |
丙氨酸氨基转移酶 | 0.050 | 0.848 | 0.024 | 0.926 | 0.192 | 0.459 |
天冬氨酸氨基转移酶 | 0.138 | 0.597 | 0.232 | 0.370 | 0.132 | 0.612 |
血清总蛋白 | -0.176 | 0.499 | 0.293 | 0.254 | -0.072 | 0.783 |
白蛋白 | -0.151 | 0.564 | 0.293 | 0.254 | 0 | 1.000 |
血葡萄糖 | 0.025 | 0.924 | 0.110 | 0.675 | -0.193 | 0.459 |
血尿素氮 | 0.302 | 0.240 | -0.244 | 0.345 | -0.048 | 0.855 |
血肌酐 | 0.427 | 0.087 | -0.317 | 0.215 | -0.072 | 0.783 |
血尿酸 | 0.377 | 0.136 | -0.415 | 0.098 | -0.072 | 0.783 |
总胆固醇 | 0.151 | 0.564 | -0.244 | 0.345 | -0.313 | 0.222 |
三酰甘油 | 0.251 | 0.331 | -0.244 | 0.345 | -0.361 | 0.155 |
高密度脂蛋白 | 0.031 | 0.911 | 0.346 | 0.206 | 0.278 | 0.315 |
低密度脂蛋白 | 0.047 | 0.867 | -0.142 | 0.614 | -0.139 | 0.620 |
钙 | 0.038 | 0.886 | 0.244 | 0.345 | -0.096 | 0.713 |
无机磷 | 0.176 | 0.499 | -0.525 | 0.030 | 0.072 | 0.783 |
镁 | 0.417 | 0.096 | 0.012 | 0.963 | -0.012 | 0.963 |
钾 | 0.201 | 0.439 | -0.634 | 0.006 | -0.409 | 0.103 |
钠 | -0.226 | 0.383 | -0.305 | 0.234 | -0.144 | 0.580 |
24 h尿蛋白定量 | 0.503 | 0.040 | -0.366 | 0.149 | -0.361 | 0.155 |
血红蛋白 | 0.251 | 0.330 | -0.085 | 0.744 | -0.156 | 0.549 |
血小板计数 | -0.063 | 0.811 | -0.232 | 0.370 | -0.289 | 0.261 |
尿红细胞检查(镜检)/HPF | -0.202 | 0.436 | -0.147 | 0.572 | 0.085 | 0.746 |
eGFR | -0.352 | 0.166 | 0.268 | 0.298 | 0.072 | 0.783 |
临床指标 | 气虚证 | 阴虚证 | 血瘀证 | |||
---|---|---|---|---|---|---|
rs值 | P值 | rs值 | P值 | rs值 | P值 | |
M病变 | 0.288 | 0.263 | -0.132 | 0.612 | 0.203 | 0.434 |
E病变 | 0.185 | 0.478 | -0.299 | 0.244 | 0.236 | 0.362 |
S病变 | -0.185 | 0.478 | -0.209 | 0.420 | -0.236 | 0.362 |
T病变 | 0.207 | 0.207 | 0.161 | 0.537 | 0.502 | 0.040 |
C病变 | 0.030 | 0.908 | -0.132 | 0.612 | -0.044 | 0.868 |
Table 7 Correlation analysis of pathological indices and TCM syndromes in IgA nephropathy patients with malignant hypertension
临床指标 | 气虚证 | 阴虚证 | 血瘀证 | |||
---|---|---|---|---|---|---|
rs值 | P值 | rs值 | P值 | rs值 | P值 | |
M病变 | 0.288 | 0.263 | -0.132 | 0.612 | 0.203 | 0.434 |
E病变 | 0.185 | 0.478 | -0.299 | 0.244 | 0.236 | 0.362 |
S病变 | -0.185 | 0.478 | -0.209 | 0.420 | -0.236 | 0.362 |
T病变 | 0.207 | 0.207 | 0.161 | 0.537 | 0.502 | 0.040 |
C病变 | 0.030 | 0.908 | -0.132 | 0.612 | -0.044 | 0.868 |
指标 | B | SE | Waldχ2值 | P值 | OR值 | 95%CI |
---|---|---|---|---|---|---|
形寒肢冷 | -0.724 | 0.614 | 1.392 | 0.238 | 0.485 | (0.146,1.614) |
肌肤干燥 | -0.836 | 0.795 | 1.106 | 0.293 | 0.433 | (0.091,2.058) |
爪甲青紫 | 2.547 | 0.916 | 7.733 | 0.005 | 12.769 | (2.121,76.882) |
口唇青紫 | -0.414 | 0.617 | 0.450 | 0.502 | 0.661 | (0.197,2.217 ) |
面色晦暗 | -0.773 | 0.613 | 1.590 | 0.207 | 0.462 | (0.139,1.535) |
颧红 | 1.037 | 0.764 | 1.842 | 0.175 | 2.821 | (0.631,12.618) |
头痛 | 2.190 | 0.595 | 13.553 | <0.001 | 8.933 | (2.784,28.663) |
视物模糊 | 1.990 | 0.589 | 11.424 | 0.001 | 7.314 | (2.307,23.189) |
飞蚊症 | 2.702 | 0.777 | 12.105 | 0.001 | 14.909 | (3.254,68.311) |
耳聋 | 1.702 | 0.680 | 6.263 | 0.012 | 5.486 | (1.446,20.809) |
口干喜饮 | 2.416 | 0.604 | 16.022 | <0.001 | 11.200 | (3.431,36.557) |
喜热饮 | -0.934 | 0.675 | 1.913 | 0.167 | 0.393 | (0.105,1.476) |
恶心 | 1.535 | 0.663 | 5.369 | 0.020 | 4.643 | (1.267,17.013) |
胁肋胀满 | -0.967 | 1.077 | 0.806 | 0.369 | 0.380 | (0.046,3.138) |
四肢倦怠 | 1.267 | 0.573 | 4.888 | 0.027 | 3.550 | (1.155,10.914) |
肢体关节疼痛 | -0.629 | 0.800 | 0.617 | 0.432 | 0.533 | (0.111,2.559) |
泄泻 | 0.758 | 0.883 | 0.737 | 0.391 | 2.133 | (0.378,12.034) |
Table 8 Univariate Logistic regression analysis of TCM indicators associated with malignant hypertension in IgA nephropathy
指标 | B | SE | Waldχ2值 | P值 | OR值 | 95%CI |
---|---|---|---|---|---|---|
形寒肢冷 | -0.724 | 0.614 | 1.392 | 0.238 | 0.485 | (0.146,1.614) |
肌肤干燥 | -0.836 | 0.795 | 1.106 | 0.293 | 0.433 | (0.091,2.058) |
爪甲青紫 | 2.547 | 0.916 | 7.733 | 0.005 | 12.769 | (2.121,76.882) |
口唇青紫 | -0.414 | 0.617 | 0.450 | 0.502 | 0.661 | (0.197,2.217 ) |
面色晦暗 | -0.773 | 0.613 | 1.590 | 0.207 | 0.462 | (0.139,1.535) |
颧红 | 1.037 | 0.764 | 1.842 | 0.175 | 2.821 | (0.631,12.618) |
头痛 | 2.190 | 0.595 | 13.553 | <0.001 | 8.933 | (2.784,28.663) |
视物模糊 | 1.990 | 0.589 | 11.424 | 0.001 | 7.314 | (2.307,23.189) |
飞蚊症 | 2.702 | 0.777 | 12.105 | 0.001 | 14.909 | (3.254,68.311) |
耳聋 | 1.702 | 0.680 | 6.263 | 0.012 | 5.486 | (1.446,20.809) |
口干喜饮 | 2.416 | 0.604 | 16.022 | <0.001 | 11.200 | (3.431,36.557) |
喜热饮 | -0.934 | 0.675 | 1.913 | 0.167 | 0.393 | (0.105,1.476) |
恶心 | 1.535 | 0.663 | 5.369 | 0.020 | 4.643 | (1.267,17.013) |
胁肋胀满 | -0.967 | 1.077 | 0.806 | 0.369 | 0.380 | (0.046,3.138) |
四肢倦怠 | 1.267 | 0.573 | 4.888 | 0.027 | 3.550 | (1.155,10.914) |
肢体关节疼痛 | -0.629 | 0.800 | 0.617 | 0.432 | 0.533 | (0.111,2.559) |
泄泻 | 0.758 | 0.883 | 0.737 | 0.391 | 2.133 | (0.378,12.034) |
指标 | B | SE | Waldχ2值 | P值 | OR值 | 95%CI |
---|---|---|---|---|---|---|
头痛 | 2.066 | 0.801 | 6.658 | 0.010 | 7.895 | (1.643,37.935) |
视物模糊 | 1.705 | 0.774 | 4.853 | 0.028 | 5.499 | (1.207,25.053) |
口干喜饮 | 2.310 | 0.756 | 9.334 | 0.002 | 10.079 | (2.289,44.373) |
爪甲青紫 | 2.908 | 1.086 | 7.167 | 0.007 | 18.312 | (2.179,153.884) |
Table 9 Multivariate Logistic regression analysis of TCM indicators associated with malignant hypertension in IgA nephropathy
指标 | B | SE | Waldχ2值 | P值 | OR值 | 95%CI |
---|---|---|---|---|---|---|
头痛 | 2.066 | 0.801 | 6.658 | 0.010 | 7.895 | (1.643,37.935) |
视物模糊 | 1.705 | 0.774 | 4.853 | 0.028 | 5.499 | (1.207,25.053) |
口干喜饮 | 2.310 | 0.756 | 9.334 | 0.002 | 10.079 | (2.289,44.373) |
爪甲青紫 | 2.908 | 1.086 | 7.167 | 0.007 | 18.312 | (2.179,153.884) |
[1] |
|
[2] |
|
[3] |
|
[4] |
陈仆,陈香美,谢院生,等. 伴MHTIgA肾病的临床病理特征及其与肾血管病变的相关性[J]. 中华肾脏病杂志,2008,24(6):392-397. DOI:10.3321/j.issn:1001-7097.2008.06.005.
|
[5] |
|
[6] |
陈天新,陈波,陈薪薪,等. 伴与不伴原发性肾脏病的MHT肾损害临床病理特点及预后对比分析[J]. 中华高血压杂志,2020,28(9):900. DOI:10.16439/j.cnki.1673-7245.2020.09.030.
|
[7] | |
[8] |
|
[9] |
|
[10] |
中华急诊医学教育学院,北京市心肺脑复苏重点实验室,首都医科大学附属北京朝阳医院急诊医学临床研究中心,等. 中国高血压急症诊治规范[J]. 中华急诊医学杂志,2020,29(9):1154-1161. DOI:10.3760/cma.j.issn.1671-0282.2020.09.003.
|
[11] |
|
[12] |
陈香美,邓跃毅,谢院生. IgA肾病西医诊断和中医辨证分型的实践指南[J]. 中国中西医结合杂志,2013,33(5):583-585.
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
张惠雅,窦艳娜,刘栋,等. 血清IgM水平与IgA肾病疾病严重程度及预后的相关性[J]. 中华肾脏病杂志,2020,36(1):41-44. DOI:10.3760/cma.j.issn.1001-7097.2020.01.007.
|
[19] |
温碧玉. 血清IgG与IgA肾病不良预后的相关性研究[D]. 太原:山西医科大学,2020.
|
[20] |
|
[21] |
徐迎华. 狼疮性肾炎肾小管间质损害相关分析[D]. 天津:天津医科大学,2018.
|
[22] |
程小红,于小勇,毛加荣. IgA肾病的病理改变与中医微观辨证[J]. 中国中西医结合肾病杂志,2014,15(2):185-186.
|
[23] | |
[24] |
占永立,李秀英,李深,等. 17例肾性MHT临床与病理分析[J]. 中国中西医结合肾病杂志,2006,7(2):101-103. DOI:10.3969/j.issn.1009-587X.2006.02.014.
|
[25] |
陈一峰,方寒蕊,王浩,等. 高血压200例脉象及病机分析[J]. 中国社区医师,2021,37(27):91-92. DOI:10.3969/j.issn.1007-614x.2021.27.045.
|
[26] | |
[27] |
廖辉,李丹萍,陈强,等. "泻南补北"法治疗阴虚阳亢型高血压病疗效观察[J]. 中国针灸,2006,26(2):91-93.
|
[28] |
蔺晓源,杨晓丹,姚福胜,等. 原发性高血压病"本虚标实"的中医病机与治疗[J]. 中医药学报,2018,46(6):10-12. DOI:10.19664/j.cnki.1002-2392.180169.
|
[29] |
杨晓萍,唐岚,张琪琳,等. 高血压性肾损害的中医症状证型分析[J]. 山东中医药大学学报,2014,38(1):28-30. DOI:10.16294/j.cnki.1007-659x.2014.01.008.
|
[30] |
焦欣,蔺晓源,雍苏南. 基于名老中医经验的高血压病病名、病因、病机、证型研究[J]. 中医药信息,2020,37(4):31-35. DOI:10.19656/j.cnki.1002-2406.200095.
|
[1] | QIN Fengyin, ZHANG Qishan, LAI Jinjia, HUANG Yimin, HAN Guoyin, SUN Xinglan, WANG Fen, TAN Yibing. Current Status and Influencing Factors of the Intention to Screen for High-risk Stroke among Community Residents in Guangdong [J]. Chinese General Practice, 2023, 26(34): 4283-4289. |
[2] | HAO Aihua, ZENG Weilin, LI Guanhai, XIA Yinghua, CHEN Liang. Current Situation of the Construction of Family Doctor Team: an Investigation Based on the Perspective of General Practitioners [J]. Chinese General Practice, 2023, 26(34): 4261-4268. |
[3] | LI Dianjiang, PAN Enchun, SUN Zhongming, WEN Jinbo, WANG Miaomiao, WU Ming, SHEN Chong. The Current Status and Influencing Factors of Clinical Inertia in Type 2 Diabetes Patients in Community [J]. Chinese General Practice, 2023, 26(34): 4296-4301. |
[4] | WANG Yue, CHEN Qing, LIU Lurong. Detection Rate of Depression and Its Influencing Factors in Chinese Elderly: a Meta-analysis [J]. Chinese General Practice, 2023, 26(34): 4329-4335. |
[5] | WANG Lina, GAO Pengfei, CAO Fan, GE Ying, YAN Wei, HE Daikun. Analysis of the Prevalence and Influencing Factors of Non-alcoholic Fatty Liver Disease in Different Gender Groups [J]. Chinese General Practice, 2023, 26(33): 4143-4151. |
[6] | ZHANG Jin, DING Zhiguo, QI Shuo, LI Ying, LI Weiqiang, ZHANG Yuanyuan, ZHOU Tong. Relationship between Serum Thyroid Hormone Levels and Prognosis during Hospitalization in Heart Failure Patients [J]. Chinese General Practice, 2023, 26(33): 4125-4129. |
[7] | ZHOU Yuyu, GAO Chuan, CUI Puan, WANG Yaping, HE Zhong. Influencing Factors of Shared Decision Making between Doctors and Patients in Menopausal Hormone Therapy in Patients with Menopausal Syndrome [J]. Chinese General Practice, 2023, 26(33): 4181-4186. |
[8] | LI Qianqian, CHEN Xunrui, ZHANG Wenying, YUAN Haihua, ZHANG Yanjie, JIANG Bin, LIU Feng. Demand and Influencing Factors for Community Health Services during Chemotherapy of Patients with Advanced Cancer [J]. Chinese General Practice, 2023, 26(33): 4173-4180. |
[9] | LIANG Xuan, NA Feiyang, QIN Mengyao, YANG Hui, GUO Li, GUO Qi, REN Lei, CHEN De, LIU Donghai, ZHANG Rongfang. Clinical Characteristics and Influencing Factors of Bronchial Asthma Combined with Obstructive Sleep Apnea-hypopnea Syndrome in Children [J]. Chinese General Practice, 2023, 26(33): 4225-4230. |
[10] | GAO Dekang, WEI Shaohua, MA Xiaoming, DU Peng, XING Chungen, CAO Chun. Risk Factors for Loss of Skeletal Muscle Mass and Its Correlation with Complications after Major Hepatectomy for Liver Cancer [J]. Chinese General Practice, 2023, 26(32): 4031-4037. |
[11] | WANG Minghuan, LI Yuhong, YU Min, WANG Yougang, YU Qiaozhi, YANG Fangfang, YUAN Dehui, ZHANG Liu. Effect of Allostatic Load on Adverse Pregnancy Outcomes of Women in Late Pregnancy [J]. Chinese General Practice, 2023, 26(32): 4064-4069. |
[12] | YUAN Dehui, LI Yuhong, XIONG Min, YU Min, MA Ruiliang, YANG Fangfang, YU Qiaozhi, WANG Minghuan. Status and Influencing Factors of Allostatic Load in Pregnant Women at Different Trimesters [J]. Chinese General Practice, 2023, 26(32): 4057-4063. |
[13] | ZHANG Shuai, LI Qin, LI Dongfeng, XIAO Jinping, LI Yunpeng. A Prospective Cohort Study of Solid Fuels Use and Risk of Hypertension in Chinese Older Adults [J]. Chinese General Practice, 2023, 26(32): 4001-4006. |
[14] | ZHANG Juan, LI Haifen, LI Xiaoman, YAO Miao, MA Huizhen, MA Qiang. Construction of Recurrence Risk Prediction Model for Diabetic Foot Ulcer on the Basis of Logistic Regression, Support Vector Machine and BP Neural Network Model [J]. Chinese General Practice, 2023, 26(32): 4013-4019. |
[15] | GAO Jing, ZHOU Shangcheng, GAO Sande, ZOU Guanyang, CHEN Yingyao. Health-related Quality of Life and Its Influencing Factors in Patients with Prevention of Disease in Traditionnal Chinese Medicine based on EQ-5D-5L Scale [J]. Chinese General Practice, 2023, 26(32): 4043-4050. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||